Education
About Us
Working with TipRanks
Follow Us
Muneer Satter Insider Profile
11 Followers
Muneer Satter, Director, Ten Percent Owner at Immunic, holds 9.73M shares in Annexon Biosciences (Ticker: ANNX), holds 16.61M shares in Rein Therapeutics (Ticker: RNTX), holds 5.62M shares in Whitehawk Therapeutics (Ticker: WHWK). Most recently, Muneer Satter Bought ― shares of Annexon Biosciences on Nov 21, 2025 for an estimated value of $3.60M.
Muneer Satter Immunic (IMUX)Director, Ten Percent Owner
Immunic (IMUX)
Director, Ten Percent Owner
Ranked #100,534 out of 105,077 Corporate Insiders
Profitable Transactions
13 out of 46 Profitable Transactions
Average Return
-21.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Muneer Satter holds in companies
Most Profitable Insider Trade
The most profitable trade made by Muneer Satter
Muneer Satter's Trading History
Immunic
Sep 17, 2018
Director, Ten Percent Owner
Informative Sell
4.11M
$0.00
Whitehawk Therapeutics
Jan 10, 2019
Director, Ten Percent Owner
Informative Buy
149.95K
$14.00M
Rein Therapeutics
Jan 08, 2021
In connection with its original investment, SMTP h, Director
Informative Buy
9.90M
$22.59M
Annexon Biosciences
Nov 21, 2025
Director
Informative Buy
3.60M
$44.85M
Akebia Therapeutics
Jul 11, 2017
Director
Informative Buy
15.00M
$3.08M
HeartWare International
―
―
―
$41.40M
Eledon Pharmaceuticals
Sep 24, 2014
Ten Percent Owner
Informative Buy
2.25M
$2.80M
DFC Global
―
―
―
―
List of latest transactions for each holding click on a transaction to see Muneer Satter's performance on stock
You May Also Like
Muneer Satter insider profile FAQ
What is the percentage of profitable transactions made by Muneer Satter?
The percentage of profitable transactions made by Muneer Satter is 28%.
What is the average return per transaction made by Muneer Satter?
The average return per transaction made by Muneer Satter is -21.20%.
What stocks does Muneer Satter hold?
Muneer Satter holds: IMUX, WHWK, RNTX, ANNX, AKBA, HTWR, ELDN, DLLR stocks.
What was Muneer Satter’s latest transaction?
Muneer Satter latest transaction was an Informative Buy of $3.60M.
What was Muneer Satter's most profitable transaction?
Muneer Satter’s most profitable transaction was an Informative Buy of IMUX stock on April 23, 2014. The return on the trade was 138.20%.
What is Muneer Satter's role in Immunic?
Muneer Satter's role in Immunic is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.